Vi dækker
EADV | European Academy of Dermatology and Venereology
EADV 2025


EADV 2025: Psoriasis Treatment and Work Productivity Outcomes
/ Kåre Steinar Tveit
EADV 2025: Expanding the Therapeutic Role of Botulinum Toxin in Dermatology
/ Oliver Philip Kreyden
EADV 2025: Advancing Treatment Frontiers in Hidradenitis Suppurativa
/ Thrasyvoulos Tzellos
Diagnostic Challenges for Immunobullous Disorders in Elderly Patients in Lagos
/ Viola Ikebudu Adaeze
Non-Medical Switches of Biosimilar in Psoriasis Treatment Appears Safe
/ Christopher Willy Schwarz
High-Intensity Focused Ultrasound Reduced/Eliminated 76% of Tumors in Patients with Cutaneous Neurofibromas
/ Katrine Elisabeth Karmisholt